This study provides compelling evidence that inherited variations in the CTLA-4 immune checkpoint gene establish a genetic predisposition for both HCV persistence and subsequent HCC by promoting a state of progressive immune dysregulation. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.